Clinical Trials Logo

Fetal Weight clinical trials

View clinical trials related to Fetal Weight.

Filter by:

NCT ID: NCT03206281 Not yet recruiting - Clinical trials for Ultrasonography, Prenatal

Tall Stature Women Fetal Weight Estimation

TSFW
Start date: July 5, 2017
Phase: N/A
Study type: Observational [Patient Registry]

To investigate the difference of clinical VS sonographic fetal weight estimation of tall women stature (above 10t percentile)

NCT ID: NCT03002246 Completed - Clinical trials for Fetal Growth Retardation

Automated Fetal Weight Estimation: A Multicenter Validation Using Fractional Limb Volume

Start date: January 6, 2017
Phase:
Study type: Observational

This trial is a collaborative study between 4 sites worldwide. A total of 600 research subjects will be enrolled. We will investigate the validity of using 5D Limb Volume software to improve on estimated fetal weight predictions over a broad range of gestational ages. The purpose is to compare the accuracy and precision of birth weight predictions based on this new technology as compared to the current 2D birth weight prediction models.

NCT ID: NCT02713568 Completed - Fetal Macrosomia Clinical Trials

Estimation of Fetal Weight by MR Imaging to PREdict Neonatal MACROsomia (PREMACRO Study)

Start date: March 8, 2016
Phase: N/A
Study type: Interventional

Macrosomia and growth restriction are important causes of perinatal morbidity, at or near to term. However, clear identification of 'at risk' foetuses is difficult and clinical estimates of fetal weight are poor. Historically, ultrasound has been used as a second line in such cases but the accuracy of this imaging modality in the mid- to late third trimester is also limited. Estimated fetal weight (EFW) is an important part of the clinical assessment and is used to guide obstetric interventions, when a fetus is small or large for dates. It frequently is the single most important component guiding interventions, such as induction of labour or Caesarean section. Due to the imprecision of ultrasound-derived EFW, particularly in cases of suspected macrosomia in the 3rd trimester, the investigators believe that these estimates should not be used to make important obstetric decisions regarding mode and timing of delivery and that a more accurate method of assessment could produce better outcomes by restricting interventions to those foetuses at greatest risk. Some publications have already demonstrated that magnetic resonance (MR) imaging derived-EFW close to delivery, is more accurate than ultrasound The goal of the present study is thus to compare the performance of magentic resonance imaging derived-EFW, versus ultrasound derived-EFW at 36 weeks of gestation, regarding the prediction of neonatal macrosomia.

NCT ID: NCT02473991 Recruiting - Pregnancy Clinical Trials

Correlation Between Placental Thickness in the Second and Third Trimester and Fetal Weight

Start date: March 2015
Phase: N/A
Study type: Observational

The aim of this prospective longitudinal study was to investigate the relationship between placental thickness during the second and third trimesters and placental and birth weights.

NCT ID: NCT02396654 Completed - Fetal Weight Clinical Trials

5D LB Ultrasound in Determination of Fetal Weight in Normal Pregnancy : A Pilot Study

Start date: March 2015
Phase: N/A
Study type: Observational

5D and 2D ultrasound will be done to normal pregnant women between 37 to 42 weeks gestation and fetal weight will be estimated using the hadlock formula using biometry measured by both ultrasounds. Accuracy of 5D ultrasound in determining fetal weight will be determined.